Article Details

AstraZeneca acquires CinCor in $1.8B deal to boost its cardiorenal pipeline

Retrieved on: 2023-01-09 17:27:04

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca acquires CinCor in $1.8B deal to boost its cardiorenal pipeline. View article details on hiswai:

Excerpt

The move gives AstraZeneca access to CinCor's baxdrostat, an aldosterone synthase inhibitor being investigated for treatment-resistant ...

Article found on: www.mmm-online.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up